MarketScreener Editorial Features Pardes Biosciences, Inc.
Equities
PRDS
US69945Q1058
MarketScreener Editorial Features
ANALYST RECOMMENDATIONS : Admiral, Hiscox, National Grid, Qiagen, Unilever... | January 17, 2022 at 11:12 am | |
MarketScreener’s World Press Review : January 13, 2022 | January 13, 2022 at 12:50 pm |